Country
United States
The US Food and Drug Administration has cautioned against altering the dosing regimen for Covid-19 vaccines launched on the US market, saying that any changes not supported by clinical trial data would be “concerning.” The agency specifically warned against using a single dose r
Full text available to subscribers only. Click here for information on subscribing to MedNous.